Shein's transport carbon emissions rise in 2024
The retailer also disclosed that its 2023 transport emissions were 18% higher than previous estimates following a recalculation. The recalculated 2023 emissions, previously reported at 6.35 million tonnes (mt), reflect an updated methodology.
The company is shifting towards producing, packaging and shipping closer to its customers to reduce emissions and improve efficiency.
The company states that its strategic approach to reducing emissions is concentrated on the two categories that contribute most significantly to its carbon footprint: purchased goods and services, and upstream transportation and distribution.
These sectors are jointly responsible for 96% of its emissions, according to its short-term goals set for 2024.
In addressing transportation and distribution emissions, Shein will implement measures in two key areas.
The first is minimising transportation distances. It plans to refine the company's global logistics network and enhance route planning to favour land, sea or combined transport methods over air freight.
The goal is to localise production, packaging and shipping processes in proximity to the customer base. This strategy is intended not only to reduce emissions but also to cut down on delivery times and shipping expenses.
The second area is the enhancement of transport efficiency. It aims to transport its products more efficiently by adopting vehicles with lower emissions, such as electric or hybrid options, and by optimising load and packaging efficiency, maximising the capacity of each shipment and decreasing the total number of shipments.
The company's emissions reduction targets, which havea been approved by the Science-Based Targets Initiative (SBTi), aim for a 25% reduction in its Scope 3 emissions [indirect greenhouse gas emissions that occur in a company's value chain, but are not directly controlled by the company] by 2030 from 2023 levels.
In addressing supply chain concerns, Shein terminated 12 supplier relationships in 2024 due to policy violations - an increase from five in 2023.
The company also conducted 4,288 on-site audits of suppliers and subcontractors in China, up from 3,990 the previous year.
"Shein's transport carbon emissions rise in 2024" was originally created and published by Retail Insight Network, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 hours ago
- Yahoo
Shein, Temu Sales Slide After Losing US Duty-Free Loophole
Temu's struggling to sell its dizzying array of ultra-budget goodies ($7 sneakers, $15 rugs, $3 bearded dragon cowboy costumes) as American shoppers ditch the Chinese retailer. Half of Temu's monthly US users left the marketplace between March and June, according to Sensor Tower, slashing its total shoppers to 40 million. Fast-fashion rival Shein's monthly users dropped 12% to 41 million in the same time frame. There's more than one reason for the declines. In May, POTUS Trump scrapped the 'de minimis' exemption that had allowed Shein and Temu to ship packages worth less than $800 to the US duty-free. At the same time, his administration's fluctuating double-digit tariffs have hit the retailers' supply chains. READ ALSO: Powell Blames Rate-Cut Delays on Tariffs and Ford, GM Notch Sales Surge as Detroit Braces for Slump Shein and Temu quickly became top US retailers by hawking ultra-cheap, heavily marketed products. Temu spent millions on its 'Shop Like a Billionaire' Super Bowl ads, while Shein splurged on social media. Both retailers were able to keep their prices low and stay on top of trends by drop-shipping products directly to Americans' doors from Chinese factories, rather than sending bulk shipments to warehouses first. Now, Shein and Temu are trying new tactics: Temu said it stopped shipping goods from China to the US in March, only displaying products from its US warehouses on its US site. Shein is reportedly expanding its production in India, with plans to start shipping India-made clothes to the US within a year. Both Temu and Shein have shifted focus to non-US shoppers. While the retailers slashed ad spending in the US, they've jacked up marketing budgets for the EU and UK by double-digit percentages. Temu's users increased by more than 70% in France and Spain last month, and Shein's UK users rose by as much as 20%. However, both the EU and the UK are considering levying import duties. Shopping Around: Both Shein and Temu won over US customers by racing to the bottom of the bargain bin and leveraging Chinese factories to churn out thousands of trendy tops and more. Any price hikes and supply-chain slowdowns resulting from the demise of de minimis could prompt shoppers to return to rivals like Amazon. However, retailers may be fighting over thinner wallets. Zara-parent Inditex and H&M both reported weaker second quarters than analysts expected. This post first appeared on The Daily Upside. To receive delivering razor sharp analysis and perspective on all things finance, economics, and markets, subscribe to our free The Daily Upside newsletter. Sign in to access your portfolio
Yahoo
8 hours ago
- Yahoo
Pfizer terminates study of CD47 in blood cancer due to low recruitment
Pfizer has terminated a Phase II study of its CD47 immune checkpoint inhibitor, maplirpacept, due to low recruitment. In an update on the company stated the study (NCT05626322) was terminated due to 'the inability to recruit the planned number of subjects', adding it was not due to any safety or efficacy concerns. The listing states only six patients were enrolled, much lower than the 70 the company had initially hoped to enrol when the study was first recorded on the registry in 2022. The study had hoped to evaluate the efficacy and safety of a combination therapy of maplirpacept with Monjuvi (tafasitamab) and Revlimid (lenalidomide) in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). Pfizer acquired maplirpacept during a $2.3bn buyout of Trillium Therapeutics in 2021. Clinical Trials Arena reached out to Pfizer for comment but the company did not respond before publication. This is the second study that Pfizer has terminated, with a Phase I trial of the CD47 in peripheral T cell lymphoma (PTCL) being terminated in August 2024. The therapy is still being evaluated in a Phase II investigator-led study (NCT05507541) in combination with Keytruda (pembrolizumab) in patients with relapsed or refractory DLBCL. Other than this, there are no other active studies of the drug in any indication. If approved, GlobalData analysts predict global sales of the drug to reach $120m in 2031. GlobalData is the parent company of Clinical Trials Arena. Pfizer is not the only company to have struggled with the CD47 pathway, with Gilead Sciences also ending all Phase III clinical trials of magrolimab in blood cancers, stating that an 'increased risk of death' had been detected. Gilead acquired magrolimab through a $4.9bn acquisition of its original developer Forty Seven in 2021. AbbVie has also cut ties with its CD47 partner I-Mab, stopping all development of lemzoparlimab, which was being investigated in myelodysplastic syndromes. In April 2025, ALX Oncology's CD47-blocker evorpacept, in combination with MSD's blockbuster Keytruda (pembrolizumab), failed to show benefit in two Phase II trials. "Pfizer terminates study of CD47 in blood cancer due to low recruitment" was originally created and published by Clinical Trials Arena, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
14 hours ago
- Yahoo
IMCD awarded EcoVadis Platinum medal
Rotterdam, The Netherlands (02 July 2025) – IMCD N.V. ("IMCD" or "Company"), a global leading partner for the distribution and formulation of speciality chemicals and ingredients, announces it has been awarded the Platinum medal by EcoVadis. This recognition places IMCD in the top 1% of companies globally assessed by EcoVadis for sustainability in the last 12 months. IMCD achieved an overall score of 84 points. EcoVadis is a globally recognised provider of business sustainability ratings, evaluating companies' ESG practices and performance in four areas: environment, labour & human rights, ethics, and sustainable procurement. The EcoVadis methodology is aligned with leading sustainability standards and frameworks, including the Global Reporting Initiative (GRI), United Nations Global Compact (UNGC), and ISO. Notable performance highlights from this year's assessment include: Sustainable procurement - Structured supplier screening and auditing practices, supported by IMCD's Together for Sustainability (TfS) membership, were positively evaluated by EcoVadis. Social responsibility - Training and development programmes, including Women in Leadership and Rising Leaders, contributed to an increased score. Environmental initiatives - Recognition was given for the Company's efforts aimed at reducing emissions and commitment to align with the Science Based Targets initiative (SBTi). 'Receiving the EcoVadis Platinum medal is a meaningful confirmation that our efforts to embed sustainable practices into our daily operations are paying off. It reassures our business partners that IMCD meets ESG standards across all areas of business', said Cecile Westerhuis, Group Director Sustainability. 'We still have more to do though, and we focus our efforts on supporting the sustainability journey of our customers and collaborating with industry partners to scale initiatives that enhance data transparency and reduce Scope 3 emissions.' - xxx- About IMCD IMCD, based in Rotterdam, The Netherlands, is a leading global partner for the distribution and formulation of speciality chemicals and ingredients. IMCD is an expert solutions provider and adds sustainable value to the supply chain. Every day professionals focus on providing the best service through commercial and operational excellence. The company is mindful of the role they play in creating a better planet for all and formulates with consciousness and executes with care, to address business challenges of tomorrow, in partnership and transparency. In 2024, with over 5,100 employees, IMCD realised revenues of EUR 4,728 million. IMCD N.V.'s shares are traded at Euronext Amsterdam (symbol: IMCD) and included in the Dutch ESG AEX index, as one of 25 companies within the AEX and AMX indices demonstrating best ESG practices. For further information, please visit Media contact Muriel Werlé Corporate Communications Director+31 10 290 86 14 mediarelations@ Investor relations contact Tosca Holtland Head of Investor Relations+31 10 290 86 53ir@ Attachment PR IMCD awarded EcoVadis Platinum Medal_20250702Sign in to access your portfolio
